Fig. 2.
Fig. 2. Expression of c-Rel protein and detection of changes of the. / REL locus in tonsillar tissue and in classical Hodgkin lymphoma. (A) In lymphofollicular tonsillar hyperplasia, the germinal center B cells stain c-Rel+ predominantly in the cytoplasm; follicular dentric cells and macrophages are c-Rel− (Ai). In the extrafollicular region (Aii), intermingled immunoblasts are c-Rel+; bars = 37.5μm. (B) In cHL1, with balanced genomic status for REL by CGH and FICTION, the HRS cells are c-Rel protein−; bar equals 25 μm. (C) Strong c-Rel staining is limited to the cytoplasm in the vast majority of HRS in cHL3, with balanced genomic status forREL; bar equals 25 μm. (Di) Partial CGH karyotype of cHL24 showing a high-level DNA amplification on the short arm of chromosome 2 including chromosomal bands 2p13-p16, as shown by the massive deviation of the ratio profile to the right. In this case, REL was shown to be amplified by FICTION analysis. (Dii) Immunohistochemically, the HRS cells of the case shown in Di show accumulation of c-Rel in the nucleus and in the cytoplasm; bar equals 25 μm. (E) cHL with a t(2;22)(p16;q12) showing a strong cytoplasmic and nuclear staining of c-Rel in HRS cells; bar equals 15 μm. (F) Immunhistochemistry of cHL15 reveals a consistent c-Rel nuclear staining of HRS cells; bar equals 37.5 μm. The inset figure shows a multicolor FICTION assay of this cHL sample combining FISH with probes for the REL(green) and BCL11A (pink) loci as well as for the centromere of chromosome 2 (CEP2; red) and simultaneous detection of the c-Rel protein using antiserum 265 (blue). The depicted Hodgkin cell displays a nuclear c-Rel expression and an amplification of the RELand BCL11A oncogene loci indicated by a number of green and pink signals clearly exceeding that of the red centromeric probe. (G) Application of the same multicolor FICTION assay as in panel F to cHL18. The Hodgkin cell with 5 copies of the centromere of chromosome 2 and 7 copies of the REL and BCL11A loci has strong nuclear c-Rel positivity; 2 bystander cells with regular signal patterns for the REL and BCL11A loci display only background staining of c-Rel. (Hi) Example of heterogeneous c-Rel expression in HRS cells (cHL5). Two HRS cells show strong nuclear positivity for c-Rel, while the HRS cell on the upper right side has staining limited to the cytoplasm; bar equals 15 μm. (Hii) FICTION assay of the same cHL sample as in Hi, combining the c-Rel antiserum 265 (blue) with probes for REL (green) and the centromere of chromosome 2 (CEP2; red). The binucleated HRS cell containing supernumerary copies of the REL locus as compared with the number of signals for CEP2 shows strong nuclear and slight cytoplasmic c-Rel staining; as internal control, surrounding bystander cells feature a regular hybridization pattern. Note that in the HRS cell the size of several signals derived from the REL probe is larger than that located in the nuclei of bystander cells. This is caused by the presence of small duplications involving theREL locus.

Expression of c-Rel protein and detection of changes of the

REL locus in tonsillar tissue and in classical Hodgkin lymphoma. (A) In lymphofollicular tonsillar hyperplasia, the germinal center B cells stain c-Rel+ predominantly in the cytoplasm; follicular dentric cells and macrophages are c-Rel (Ai). In the extrafollicular region (Aii), intermingled immunoblasts are c-Rel+; bars = 37.5μm. (B) In cHL1, with balanced genomic status for REL by CGH and FICTION, the HRS cells are c-Rel protein; bar equals 25 μm. (C) Strong c-Rel staining is limited to the cytoplasm in the vast majority of HRS in cHL3, with balanced genomic status forREL; bar equals 25 μm. (Di) Partial CGH karyotype of cHL24 showing a high-level DNA amplification on the short arm of chromosome 2 including chromosomal bands 2p13-p16, as shown by the massive deviation of the ratio profile to the right. In this case, REL was shown to be amplified by FICTION analysis. (Dii) Immunohistochemically, the HRS cells of the case shown in Di show accumulation of c-Rel in the nucleus and in the cytoplasm; bar equals 25 μm. (E) cHL with a t(2;22)(p16;q12) showing a strong cytoplasmic and nuclear staining of c-Rel in HRS cells; bar equals 15 μm. (F) Immunhistochemistry of cHL15 reveals a consistent c-Rel nuclear staining of HRS cells; bar equals 37.5 μm. The inset figure shows a multicolor FICTION assay of this cHL sample combining FISH with probes for the REL(green) and BCL11A (pink) loci as well as for the centromere of chromosome 2 (CEP2; red) and simultaneous detection of the c-Rel protein using antiserum 265 (blue). The depicted Hodgkin cell displays a nuclear c-Rel expression and an amplification of the RELand BCL11A oncogene loci indicated by a number of green and pink signals clearly exceeding that of the red centromeric probe. (G) Application of the same multicolor FICTION assay as in panel F to cHL18. The Hodgkin cell with 5 copies of the centromere of chromosome 2 and 7 copies of the REL and BCL11A loci has strong nuclear c-Rel positivity; 2 bystander cells with regular signal patterns for the REL and BCL11A loci display only background staining of c-Rel. (Hi) Example of heterogeneous c-Rel expression in HRS cells (cHL5). Two HRS cells show strong nuclear positivity for c-Rel, while the HRS cell on the upper right side has staining limited to the cytoplasm; bar equals 15 μm. (Hii) FICTION assay of the same cHL sample as in Hi, combining the c-Rel antiserum 265 (blue) with probes for REL (green) and the centromere of chromosome 2 (CEP2; red). The binucleated HRS cell containing supernumerary copies of the REL locus as compared with the number of signals for CEP2 shows strong nuclear and slight cytoplasmic c-Rel staining; as internal control, surrounding bystander cells feature a regular hybridization pattern. Note that in the HRS cell the size of several signals derived from the REL probe is larger than that located in the nuclei of bystander cells. This is caused by the presence of small duplications involving theREL locus.

Close Modal

or Create an Account

Close Modal
Close Modal